Patel Gautam

Patel Gautam is listed in filings as Director at Amneal Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 8, 2026, including sale activity. Recent filings connect the profile to Amneal Pharmaceuticals, Inc. (AMRX) and Spectrum Brands Holdings Inc (SPB). The current snapshot covers public activity from Nov 20, 2024 to May 8, 2026. Reported amounts are shown as $761.1K to $39.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.